Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Applied Use of CNQX in Neuroscience: Protocols and Troublesh
2026-07-03
CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) offers unmatched selectivity for dissecting AMPA and kainate receptor-mediated glutamatergic pathways. This article details practical workflows, optimization strategies, and real-world troubleshooting for maximizing CNQX’s value in advanced neuroscience and cardiovascular research.
-
Tamsulosin for Symptomatic Ureteral Stones: Meta-Analysis In
2026-07-03
A recent systematic review and meta-analysis confirms that Tamsulosin, a selective α₁A-adrenergic receptor antagonist, significantly improves expulsion rates and reduces expulsion time for symptomatic ureteral stones, without increasing the risk of adverse effects. These findings clarify earlier controversies and provide robust support for Tamsulosin’s clinical and research application in urological disease models.
-
WEHI-539: Advanced BCL-XL Inhibitor Workflows for Apoptosis
2026-07-02
WEHI-539 empowers researchers to dissect BCL-XL-dependent apoptosis with high selectivity, enabling breakthroughs in cancer stem cell sensitization and synthetic lethality approaches. This guide delivers actionable protocol enhancements, troubleshooting insights, and practical integration of cutting-edge findings for maximizing experimental success.
-
4-Ethylphenyl Sulfate: Experimental Workflows and Biomarker
2026-07-02
4-Ethylphenyl sulfate is transforming how scientists model gut-brain and kidney axis dysfunction, enabling reproducible workflows in neurobehavioral and renal biomarker research. This guide delivers actionable protocols, troubleshooting strategies, and insights from pioneering surface interaction studies, positioning APExBIO’s reagent for advanced translational applications.
-
Isolation and Structural Analysis of Forsythoside E from For
2026-07-01
This study details the isolation and spectroscopic identification of Forsythoside E and other phenylethanoid glycosides from Forsythia suspensa fruit. The characterization of these compounds provides a foundation for subsequent research into their mechanistic roles in immunometabolic modulation and disease models.
-
Puromycin dihydrochloride: Applied Selection and Translation
2026-07-01
Puromycin dihydrochloride empowers researchers with precise selection of pac gene-expressing cell lines and real-time translation inhibition, outperforming many traditional antibiotics in versatility and clarity of mechanistic action. Learn how to maximize its utility for robust molecular biology and translational research using evidence-backed workflows and troubleshooting strategies.
-
Caspase-3–Mediated NDUFS1 Cleavage Drives Trichothecene ROS
2026-06-30
This study uncovers a mechanistic link between caspase-3 activation, NDUFS1 cleavage, and mitochondrial ROS accumulation in trichothecene-induced hepatotoxicity. The findings illuminate the interplay between mitochondrial dysfunction and endoplasmic reticulum oxidative stress, providing new molecular targets for mitigating mycotoxin-related liver damage.
-
DiR (DiIC 18 (7)): Transforming Long-Term Cell Membrane Imag
2026-06-30
Explore how DiR (DiIC 18 (7)) unlocks new horizons in live and fixed cell membrane imaging, with a special focus on its unique near-infrared performance and practical implications for advanced cell tracking and neuronal tracing. This article delivers deep scientific insight and actionable protocols beyond standard EV tracking workflows.
-
HLY78: Wnt/β-Catenin Pathway Modulator for Advanced Research
2026-06-29
HLY78, a selective Wnt/β-catenin pathway modulator, empowers researchers to dissect and manipulate canonical Wnt signaling with precision. Its unique Axin-targeting mechanism enables robust pathway activation for studies in development, stem cell marker induction, and fibrotic disease modeling.
-
Applied Workflows with Cy5 Goat Anti-Mouse IgG (H+L) Antibod
2026-06-29
Unlock robust fluorescent detection and signal amplification in immunohistochemistry, immunocytochemistry, and advanced vaccine research with the Cy5 Goat Anti-Mouse IgG (H+L) Antibody. This guide translates bench-proven innovations into actionable protocols, troubleshooting strategies, and workflow optimizations for high-sensitivity mouse IgG detection.
-
Technical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling
2026-06-28
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus streamlines the synthesis of high-yield, randomly Cy3-labeled RNA probes for research workflows such as in situ hybridization (ISH) and Northern blotting. It is not suitable for diagnostic or clinical applications, focusing solely on reproducible, sensitive fluorescent RNA probe generation in standard laboratory settings.
-
LMO2/LDB1 Complex Drives AML Progression via Transcriptional
2026-06-27
This study demonstrates that the LMO2/LDB1 protein complex critically promotes acute myeloid leukemia (AML) cell proliferation and survival through coordinated transcriptional regulation. The findings highlight the oncogenic potential of LDB1 and its interaction with LMO2 as a promising molecular target for AML therapy.
-
Helper-Polymer FNPs Enable Stable, Lung-Targeted mRNA Delive
2026-06-26
Cao et al. (2022) introduce five-element nanoparticles (FNPs) featuring poly(β-amino esters) (PBAEs) and DOTAP, achieving lung-specific mRNA delivery with unprecedented long-term stability after lyophilization. This innovation addresses the pressing challenge of mRNA carrier instability, offering new avenues for research and clinical translation in pulmonary mRNA therapy.
-
Bedaquiline Beyond TB: Targeting Cellular Bioenergetics in R
2026-06-26
Explore how Bedaquiline, a diarylquinoline antibiotic, advances multi-drug resistant tuberculosis treatment and cancer stem cell research. This article offers a unique, bioenergetics-focused analysis and practical guidance for specialized assays.
-
PBS Liposomes (SKU K2722): Reliable Controls for Macrophage
2026-06-25
PBS Liposomes (SKU K2722) serve as rigorously validated, biologically inert controls for macrophage depletion and phagocytosis assays, underpinning reproducible in vivo experimental workflows. This article explores real-world lab challenges and demonstrates how APExBIO’s PBS Liposomes deliver sensitivity, safety, and interpretability for immunological research.